Sagar Bapat, MD, PhD, Assistant Professor, University of California, San Francisco

• Bapat’s research, Living Therapeutics: Development of a novel T cell therapy to enhance thermogenic function of adipose tissue, seeks to harness targeted cellular therapy and CRISPR technology to offer durable, preventative interventions against obesity-induced diabetes.
• “This award will enable us to pursue a novel type of living T cell-based therapy aimed at modulating adipose tissue function to promote metabolic health. By harnessing the unique mobility and functional versatility of T cells, our goal is to restore healthy tissue function and improve insulin sensitivity in metabolic and inflammatory disease. The Pathway award provides critical support to translate these insights into therapeutic strategies with the potential for long-term benefit for patients.”